Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 8, 2012 - Issue 7: Special Focus: Transplantation: from tolerance to rejection
Submit an article Journal homepage
989
Views
7
CrossRef citations to date
0
Altmetric
Meeting Report

8th International Congress on Autoimmunity: new perspectives for refractory catastrophic antiphospholipid syndrome

Ricard Cervera Servei de Malalties Autoimmunes, Hospital Clínic, Villarroel 170, 08036-Barcelona, Catalonia, Spain. [email protected]
Pages 617-619 | Published online: 10 Jan 2014

References

  • Cervera R, Espinosa G. Update on the catastrophic antiphospholipid syndrome and the “CAPS Registry”. Semin. Thromb. Hemost. 38(4), 333–338 (2012).
  • Cervera R. CAPS Registry. Lupus 21(7), 755–757 (2012).
  • Espinosa G, Berman H, Cervera R. Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmun. Rev. 10(11), 664–668 (2011).
  • Bucciarelli S, Espinosa G, Cervera R et al.; European Forum on Antiphospholipid Antibodies. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 54(8), 2568–2576 (2006).
  • Asherson RA, Espinosa G, Menahem S et al. Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin. Arthritis Rheum. 37(6), 366–372 (2008).
  • Espinosa G, Rodríguez-Pintó I, Gómez-Puerta JA, Pons-Estel G, Cervera R, for the CAPS Registry Project Group (European Forum on Antiphospholipid Antibodies). Relapsing catastrophic antiphospholipid syndrome: potential role of microangiopathic hemolytic anemia in disease relapses. Semin. Arthritis Rheum. doi:10.1016/j.semarthrit.2012.05.005 (2012) (Epub ahead of print).
  • Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rituximab treatment for resistant antiphospholipid syndrome. J. Rheumatol. 33(2), 355–357 (2006).
  • Manner H, Jung B, Tonassi L et al. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine. Am. J. Med. Sci. 335(5), 394–397 (2008).
  • van Wissen S, Bastiaansen BA, Stroobants AK et al. Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour – a case report. Lupus 17(6), 586–590 (2008).
  • Nageswara Rao AA, Arteaga GM, Reed AM, Gloor JM, Rodriguez V. Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome. Pediatr. Blood Cancer 52(4), 536–538 (2009).
  • Jamoussi SK, Zaghdoudi I, Ben Dhaou B et al. Catastrophic antiphospholipid syndrome and rituximab: a new report. Tunis Med. 87, 699–702 (2009).
  • Iglesias-Jiménez E, Camacho-Lovillo M, Falcón-Neyra D, Lirola-Cruz J, Neth O. Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab. Pediatrics 125(6), e1523–e1528 (2010).
  • Haque W, Kadikoy H, Pacha O, Maliakkal J, Hoang V, Abdellatif A. Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy. Rheumatol. Int. 30(6), 719–723 (2010).
  • Burcoglu-O’Ral A, Erkan D, Asherson R. Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. J. Rheumatol. 29(9), 2006–2011 (2002).
  • Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore). 80(6), 355–377 (2001).
  • Lonze BE, Singer AL, Montgomery RA. Eculizumab and renal transplantation in a patient with CAPS. N. Engl. J. Med. 362(18), 1744–1745 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.